News Home

Should You Sell Protalix Biotherapeutics Inc (PLX) Stock Tuesday Morning?

Tuesday, September 07, 2021 08:04 AM | InvestorsObserver Analysts
Should You Sell Protalix Biotherapeutics Inc (PLX) Stock Tuesday Morning?

Protalix Biotherapeutics Inc (PLX) has risen Tuesday morning, with the stock rising 3.11% in pre-market trading to 1.66. PLX's short-term technical score of 15 indicates that the stock has traded less bullishly over the last month than 85% of stocks on the market. In the Biotechnology industry, which ranks 140 out of 146 industries, Protalix Biotherapeutics Inc ranks higher than 36% of stocks. Protalix Biotherapeutics Inc has risen 7.33% over the past month, closing at $1.54 on August 10. During this period of time, the stock fell as low as $1.31 and as high as $1.66. PLX has an average analyst recommendation of Strong Buy. The company has an average price target of $9.75.

Overall Score - 35
PLX has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on PLX!
Protalix Biotherapeutics Inc has a Long-Term Technical rank of 4. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 96% of the market scoring higher. In the Biotechnology industry which is number 130 by this metric, PLX ranks better than 11% of stocks.

Important Dates for Investors in PLX:

-Protalix Biotherapeutics Inc is set to release earnings on 11/4/2021. During their last earnings release the company posted EPS of $-0.50. -We do not have a set dividend date for Protalix Biotherapeutics Inc at this time. Click Here To Get The Full Report on Protalix Biotherapeutics Inc (PLX)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App